The COVID-19 pandemic witnessed the greatest deployment of monoclonal antibody (mAb) therapies for an infectious disease, but all were defeated by SARS-CoV-2 evolution. As new mAbs are developed, the infectious disease community needs stewardship practices to reduce emergence of resistance.

中文翻译：

---

单一单克隆抗体不应用于 COVID-19 治疗：呼吁抗病毒管理


COVID-19 大流行见证了针对传染病的单克隆抗体 （mAb） 疗法的最大部署，但所有这些都被 SARS-CoV-2 的进化所击败。随着新 mAb 的开发，传染病界需要管理实践以减少耐药性的出现。